I1-imidazoline receptors: an update.

[1]  M. Dontenwill,et al.  Imidazoline Receptors and Cardiovascular Regulations , 1995 .

[2]  D. Nutt,et al.  Functional Studies of Specific Imidazoline‐2 Receptor Ligands , 1995, Annals of the New York Academy of Sciences.

[3]  M. Dontenwill,et al.  Antiidiotypic Antibodies as Tools to Study Imidazoline Receptors , 1995, Annals of the New York Academy of Sciences.

[4]  I. Angel,et al.  [3H]Cirazoline as a Tool for the Characterization of Imidazoline Sites , 1995, Annals of the New York Academy of Sciences.

[5]  D. Nutt,et al.  Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites. , 1995, The Journal of pharmacology and experimental therapeutics.

[6]  M. Dontenwill,et al.  Isolation of a human cerebral imidazoline-specific binding protein. , 1994, European journal of pharmacology.

[7]  D. Reis,et al.  Immunodetection of putative imidazoline receptor proteins in the human and rat brain and other tissues , 1994, Neuroscience Letters.

[8]  N. Morgan,et al.  The imidazoline site involved in control of insulin secretion: characteristics that distinguish it from I1‐ and I2‐sites , 1994, British journal of pharmacology.

[9]  M. Dontenwill,et al.  Characterization of imidazoline binding protein(s) solubilized from human brainstem: Studies with [3H]idazoxan and [3H]clonidine , 1994, Neurochemistry International.

[10]  G. Vauquelin,et al.  Imidazoline receptors, non-adrenergic idazoxan binding sites and α2-adrenoceptors in the human central nervous system , 1994, Neuroscience.

[11]  G. Bertrand,et al.  Effects of imidazolines and derivatives on insulin secretion and vascular resistance in perfused rat pancreas. , 1994, European journal of pharmacology.

[12]  D. Reis,et al.  Agmatine: an endogenous clonidine-displacing substance in the brain. , 1994, Science.

[13]  M. Dontenwill,et al.  Human brain imidazoline receptors: further characterization with [3H]clonidine. , 1994, European journal of pharmacology.

[14]  K. Sletten,et al.  Nonadrenergic imidazoline binding sites on human platelets. , 1993, The Journal of pharmacology and experimental therapeutics.

[15]  G. Head,et al.  Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[16]  J. García-Sevilla,et al.  Evidence of increased non-adrenoceptor [3H]idazoxan binding sites in the frontal cortex of depressed suicide victims , 1993, Biological Psychiatry.

[17]  J. García-Sevilla,et al.  Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease , 1993, Neuroscience Letters.

[18]  R. Kline,et al.  Renal effects of rilmenidine in anesthetized rats: importance of renal nerves. , 1993, The Journal of pharmacology and experimental therapeutics.

[19]  M. Sastre,et al.  Opposite Age‐Dependent Changes of α2A‐Adrenoceptors and Nonadrenoceptor [3H]Idazoxan Binding Sites (I2‐Imidazoline Sites) in the Human Brain: Strong Correlation of I2 with Monoamine Oxidase‐B Sites , 1993, Journal of neurochemistry.

[20]  J. Neumeyer,et al.  Visualization of multiple imidazoline/guanidinium-receptive sites. , 1993, The Journal of biological chemistry.

[21]  G. Bricca,et al.  Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortex , 1993, Neurochemistry International.

[22]  D. Faulds,et al.  Moxonidine. A review of its pharmacology, and therapeutic use in essential hypertension. , 1992, Drugs.

[23]  D. Reis,et al.  Isolation and characterization of imidazoline receptor protein from bovine adrenal chromaffin cells. , 1992, Molecular pharmacology.

[24]  A. Parini,et al.  Purification and characterization of mitochondrial imidazoline-guanidinium receptive site from rabbit kidney. , 1992, The Journal of biological chemistry.

[25]  P. Cowen,et al.  Alpha-2-adrenoceptor control of cortisol and ACTH in normal volunteers: Preliminary open trial of the effects of acute and chronic idazoxan , 1992, Psychoneuroendocrinology.

[26]  A. Rémaury,et al.  The insulin-secreting cell line, RINm5F, expresses an alpha-2D adrenoceptor and nonadrenergic idazoxan-binding sites. , 1992, The Journal of pharmacology and experimental therapeutics.

[27]  F. Gonon,et al.  Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors. , 1991, European journal of pharmacology.

[28]  N. Morgan,et al.  The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells , 1991 .

[29]  F. Gonon,et al.  An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan. , 1991, The Journal of pharmacology and experimental therapeutics.

[30]  R. Podevin,et al.  Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney. , 1991, European journal of pharmacology.

[31]  G. Vauquelin,et al.  Identification of α 2 adrenergic receptors in human frontal cortex membranes by binding of [3H]RX 821002, the 2-methoxy analog of [3H]idazoxan , 1990, Neurochemistry International.

[32]  J. Henquin,et al.  Phentolamine and yohimbine inhibit ATP‐sensitive K+ channels in mouse pancreatic β‐cells , 1990, British journal of pharmacology.

[33]  M. Dontenwill,et al.  Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit , 1990, British journal of pharmacology.

[34]  J. Wikberg,et al.  Further Characterization of the Guinea Pig Cerebral Cortex Idazoxan Receptor: Solubilization, Distinction from the Imidazole Site, and Demonstration of Cirazoline as an Idazoxan Receptor‐Selective Drug , 1990, Journal of neurochemistry.

[35]  R. Neubig,et al.  Nonadrenergic [3H]idazoxan binding sites are physically distinct from alpha 2-adrenergic receptors. , 1990, Molecular pharmacology.

[36]  W. Potter,et al.  Idazoxan: a selective alpha 2-antagonist and effective sustained antidepressant in two bipolar depressed patients. , 1989, Archives of general psychiatry.

[37]  R. Graham,et al.  Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor. , 1989, The Journal of biological chemistry.

[38]  M. Dontenwill,et al.  Rilmenidine selectivity for imidazoline receptors in human brain. , 1989, European journal of pharmacology.

[39]  M. Dontenwill,et al.  The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem. , 1989, European journal of pharmacology.

[40]  D. Langin,et al.  [3H]Idazoxan binding at non-α2-adrenoceptors in rabbit adipocyte membranes , 1989 .

[41]  J. Wikberg.  High affinity binding of idazoxan to a non-catecholaminergic binding site in the central nervous system: description of a putative idazoxan-receptor. , 1989, Pharmacology & toxicology.

[42]  J. Riffaud,et al.  Evidence for non-adrenergic binding sites for [3H]idazoxan in the smooth muscle of rabbit urethra. , 1988, European journal of pharmacology.

[43]  M. Dontenwill,et al.  Evidence for the existence of a homogeneous population of imidazoline receptors in the human brainstem. , 1988, European journal of pharmacology.

[44]  R. Podevin,et al.  Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. , 1987, Biochemical and biophysical research communications.

[45]  D. Reis,et al.  Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. , 1987, European journal of pharmacology.

[46]  D. Charney,et al.  Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action. , 1986, Archives of general psychiatry.

[47]  D. Atlas,et al.  An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure. , 1986, European journal of pharmacology.

[48]  D. Reis,et al.  An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla. , 1986, Life sciences.

[49]  J. Schwartz,et al.  The medullary cardiovascular effects of imidazolines and some GABA analogues: a review. , 1985, Journal of the autonomic nervous system.

[50]  Y. Burstein,et al.  Isolation and partial purification of a clonidine-displacing endogenous brain substance. , 1984, European journal of biochemistry.

[51]  D. Atlas,et al.  Isolation of an endogenous clonidine‐displacing substance from rat brain , 1984, FEBS letters.

[52]  J. Schwartz,et al.  The nucleus reticularis lateralis: a region highly sensitive to clonidine. , 1981, European journal of pharmacology.